Danish Pharmacovigilance Update June 2014

17 July 2014

News from the EU

  • Potentially life-threatening accidental exposure to fentanyl patches (Durogesic® etc.)
  • Combined use of medicines affecting the renin-angiotensin system (RAS) is restricted
  • EU starts review of cardiovascular risks from long-term use with high doses of ibuprofen
  • EU's list of recommendations on safety signals

News from the DHMA

  • Dose errors involving fosphenytoin (Pro-Epanutin)
  • Olanzapine prolonged-release injection (Zypadhera®) and post-injection syndrome
  • Childhood vaccinations and adverse reactions in Q1 of 2014

News in brief

  • Most recent Direct Healthcare Professional Communications (DHPCs)